Skip to Main Content

Paper Details

Alternative promoters control UGT2B17-dependent androgen catabolism in prostate cancer and its influence on progression.
Br J Cancer
14
2020
Author NameAffiliation
H??l??ne HovingtonCentre Hospitalier Universitaire de Quebec (CHU de Quebec) Research Center-Universite Laval and Faculty of Medicine
Herv?? BrissonCentre Hospitalier Universitaire de Quebec (CHU de Quebec) Research Center-Universite Laval and Faculty of Medicine
Mickael LeclercqCentre Hospitalier Universitaire de Quebec (CHU de Quebec) Research Center-Universite Laval and Faculty of Medicine
Arnaud DroitCentre Hospitalier Universitaire de Quebec (CHU de Quebec) Research Center-Universite Laval and Faculty of Medicine
Yves FradetCentre Hospitalier Universitaire de Quebec (CHU de Quebec) Research Center-Universite Laval and Faculty of Medicine
Louis LacombeCentre Hospitalier Universitaire de Quebec (CHU de Quebec) Research Center-Universite Laval and Faculty of Medicine
  • 1 - 6

Datasets

Release 1.2